‘I am a Coronary heart specialist; I am Historical to Doing Issues’: What We Heard This Week

“I am a cardiologist; I am old vogue to doing issues.” — FDA Commissioner Robert Califf, MD, all over a press briefing discussing the agency’s proposal to ban menthol in cigarettes and assorted tobacco products.

“Or no longer it’s appropriate if truth be told primary to rating the word out that we have now worthy extra tools within the toolkit now.” — Kathy Yang, PharmD, of the College of California San Francisco, on urging providers to ascertain with patients about reaching out when they’re ailing to present a purchase to rating admission to to Paxlovid.

“Why these telemedicine operations easy exist is fully perplexing.” — Slash Sawyer, MD, MBA, of the College of California Davis, on companies and products that provide prescriptions for unproven treatments, like ivermectin, for COVID-19.

“I gaze gentle at the tunnel. I appropriate construct no longer know whether or no longer it’s a practice or the solar.” — North Carolina Sen. Richard Burr (R) discussing the bid of the pandemic all over a Senate committee listening to on re-authorizing FDA users expenses.

“It does have slightly of a flavor of, right here we drag again.” — Jacob Lemieux, MD, PhD, of Massachusetts Traditional Neatly being facility, on South Africa’s fresh surge in COVID circumstances.

“There may maybe be no particular the clarification why emergency contraception tablets would maybe well additionally easy be taken after intercourse.” — Erica Cahill, MD, of Stanford College in California, on fresh be taught inspecting an oral drug combination as pre-sex birth support a watch on.

“Here is a theme all over all of tablets, the ‘lumpers and splitters.'” — David Dudzinski, MD, JD, of Massachusetts Traditional Neatly being facility, discussing fresh pointers that launched fresh categories for coronary heart failure with intermediate and improved ejection piece.

“It prices like $5 to employ this, so why no longer give it a are trying?” — Nicole Schmitt, MD, of Emory College in Atlanta, on the utilization of topical antisepsis brokers sooner than advanced facial flap reconstruction as one arrangement of decreasing surgical situation infections.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button